Skip to content
Home/Companies/Healthcare/Venatorx Pharmaceuticals
VP

Venatorx Pharmaceuticals

Healthcare·US·Active·4yr hold

Venatorx Pharmaceuticals is a healthcare company, headquartered in US.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Venatorx Pharmaceuticals?

Venatorx Pharmaceuticals is currently owned by Abingworth through Abingworth Bioventures VI (2014 vintage), since 2022.

Hand-verified · updated 2026-06-10

Abingworth
Investor
Abingworth
Abingworth Bioventures VI · 2014 · Life Sciences VC

Key facts

HQUS
SectorHealthcare
StatusActive

More from Abingworth Bioventures VI

Other portfolio companies in the same fund.

Exicure
Active
BiotechUS· 2019
Tizona Therapeutics
Active
BiotechUS· 2016
Median Technologies
Active
HealthcareFrance· 2015
Avedro
Exited 2019
MedTechUS· 2014
to
GenSight Biologics
Exited 2016
BiotechFrance· 2014
eFFECTOR Therapeutics
Exited 2021
BiotechUS· 2013
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings